Outcome Measures for Disease-Modifying Trials in Parkinson’s Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative

BACKGROUND: Multi-arm, multi-stage (MAMS) platform trials can accelerate the identification of disease-modifying treatments for Parkinson’s disease (PD) but there is no current consensus on the optimal outcome measures (OM) for this approach. OBJECTIVE: To provide an up-to-date inventory of OM for d...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez-Robles, Cristina, Weil, Rimona S., van Wamelen, Daniel, Bartlett, Michèle, Burnell, Matthew, Clarke, Caroline S., Hu, Michele T., Huxford, Brook, Jha, Ashwani, Lambert, Christian, Lawton, Michael, Mills, Georgia, Noyce, Alastair, Piccini, Paola, Pushparatnam, Kuhan, Rochester, Lynn, Siu, Carroll, Williams-Gray, Caroline H., Zeissler, Marie-Louise, Zetterberg, Henrik, Carroll, Camille B., Foltynie, Thomas, Schrag, Anette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2023
Materias:
Consensus Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578294/
https://www.ncbi.nlm.nih.gov/pubmed/37545260
http://dx.doi.org/10.3233/JPD-230051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578294/
https://www.ncbi.nlm.nih.gov/pubmed/37545260
http://dx.doi.org/10.3233/JPD-230051

Ejemplares similares